Research group

 

Clinical Trial Group

 

Lead : Prof Fahal

Coordinator: Dr. Eiman Saddig

Subgroups

  • Double-blind, randomized clinical trial for eumycetoma treatment using fosravuconazole, versus the current standard of care, daily treatment with itraconazole.
    MRC- DNDi - Eisai Ltd (Japan) Group Members

 

Diagnostics Research Group

Lead: Dr. Sahar Mubarak

Coordinator :Mr. Emmanuel Edwar Siddig

Subgroups

  • Development of field-friendly point-of-care diagnostic test for mycetoma
    MycEXomics Members
  • Protein Biobank
    MRC - Biochemistry Department, Faculty of Medicine, U of K Group Members
  • Eumycetoma molecular diagnosis
    MRC - Erasmus Medical Centre Group Members
  • Actinomycetoma molecular diagnosis
    MRC - Erasmus Medical Centre Group Members
  • In Vitro drugs sensitivity testing
    MRC - Erasmus Medical Centre Group Members
  • Fosravuconazole pharmacodynamics for Eumycetoma Treatment
    MRC - Erasmus Medical Centre Group Members

 

 Epidemiology Research Group

Lead: Prof Fahal
Coordinator : Dr. Sahar Mubarak

Subgroups

  • Mycetoma Spatial distribution
    MRC - NIHR Global Health Research Unit Members
  • Mycetoma Genetics
    MRC - NIHR Global Health Research Unit Members
  • Mycetoma spatial distruation at Eastern Sennar
    MRC - Nagasaki University. Japan Group Members
  • Mycetoma transmission route and vector control
    MRC - Vector Genetics and Control Laboratory, Faculty of Science, University of Khartoum Group Members
  • Mycetoma Spatial distribution in Sudan
    MRC - Faculty of Geographical and Environmental Sciences, University of Khartoum Group Members

 

Social Sciences Research Group

Lead :  Dr. Osama Abu Zaid
            Dr Azza Ahmed A AZZIZ

Coordinator:  Dr. Hala EL Malik

Subgroups

  • The Social Sciences for Severe Stigmatising Skin Conditions (5S) Foundation Project
    MRC - 5 S Foundation Members
  • Mycetoma Social Impact
    MRC - NIHR Global Health Research Unit Members

 

Immunopathology Research Group

Lead:  Prof. Ahmed Mudawi Musa

Coordinator:  Dr. Sahar Mubarak

Subgroups

  • Digital Spatial Profiling of the immune- microenvironment in the mycetoma granulomas
    MRC - Immunity and Infection Centre, York University
  • Immune responses of mycetoma patients during a double-blind, randomized clinical trial for eumycetoma treatment using fosravuconazole, versus the current standard of care, daily treatment with itraconazole.
    MRC- DNDi - Eisai Ltd (Japan) Group Members

 

Mycetoma Mathematical Modeling

Lead: Prof. Fahal

Coordinator: Miss Hayman

Subgroups 

  • The mathematical modelling for the histopathological diagnosis of Mycetoma
    MRC – Tours University, France Group Members
  • The mathematical modelling for the mycetoma treatment outcome
    MRC - Faculty of Mathematical Sciences, U of K, Group Members

 

Mycetoma Therapeutic Research Group

Lead: Prof. Magdi Hussein

Coordinator:

Subgroups

  • Drug repurposing for mycetoma
    MRC – Tours University, France Group Members